Rohan Palekar
2022
In 2022, Rohan Palekar earned a total compensation of $3.1M as Chief Executive Officer at 89bio, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $387,800 |
|---|---|
| Option Awards | $735,680 |
| Salary | $587,600 |
| Stock Awards | $1,401,648 |
| Other | $15,121 |
| Total | $3,127,849 |
Palekar received $1.4M in stock awards, accounting for 45% of the total pay in 2022.
Palekar also received $387.8K in non-equity incentive plan, $735.7K in option awards, $587.6K in salary and $15.1K in other compensation.
Rankings
In 2022, Rohan Palekar's compensation ranked 1,162nd out of 5,742 executives tracked by ExecPay. In other words, Palekar earned more than 79.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,162 out of 5,742 | 80th |
Division Manufacturing | 564 out of 3,128 | 82nd |
Major group Chemicals And Allied Products | 205 out of 1,416 | 86th |
Industry group Drugs | 185 out of 1,317 | 86th |
Industry Pharmaceutical Preparations | 141 out of 963 | 85th |
Source: SEC filing on April 24, 2023.
Palekar's colleagues
We found two more compensation records of executives who worked with Rohan Palekar at 89bio in 2022.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020